Related Experiment Video
Updated: Aug 13, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Molecular biology of the MEN2 gene
M Santoro1, R M Melillo, F Carlomagno
1Centro di Endocrinologia ed Oncologia Sperimentale del CNR/Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli, Naples, Italy.
Abstract:
Cancer is a genetic disease caused by 'gain of function' mutations of oncogenes and 'loss of function' mutations of tumour suppressors and of genes involved in DNA repair mechanisms. The RET gene encodes a tyrosine kinase receptor for molecules belonging to the glial cell line-derived neurotrophic factor (GDNF) family. RET is a paradigmatic example of how different mutations of a single gene can lead to different neoplastic phenotypes. Indeed, gene rearrangements, often caused by chromosomal inversions, activate the oncogenic potential of RET in a fraction of human thyroid papillary carcinomas. On the other hand, different point mutations activate RET in familial multiple endocrine neoplasia syndromes familial medullary thyroid carcinoma (FMTC), MEN-2A and MEN-2B. Little information is so far available on the biochemical mechanisms by which the potent transforming and mitogenic signals of RET are delivered to the nucleus. However, recent data indicate coupling to the Shc-Ras-MAPK pathway as a necessary step in RET signal transduction.
Insights
The RET gene, when mutated, drives cancer, particularly thyroid cancer. Different RET mutations lead to distinct cancer types by activating specific signaling pathways like Shc-Ras-MAPK.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer arises from genetic mutations in oncogenes and tumor suppressors.
- The RET gene, encoding a tyrosine kinase receptor, is implicated in various cancers.
- RET mutations are known drivers in thyroid papillary carcinomas and familial endocrine neoplasia syndromes.
Purpose of the Study:
- To elucidate the role of the RET gene in different neoplastic phenotypes.
- To investigate the biochemical mechanisms of RET-mediated signal transduction.
- To understand how RET mutations contribute to cancer development.
Main Methods:
- Analysis of RET gene rearrangements and point mutations.
- Investigation of RET signaling pathways.
- Biochemical assays to study signal transduction.
Main Results:
- RET gene rearrangements activate oncogenic potential in thyroid papillary carcinomas.
- Specific point mutations in RET are linked to familial medullary thyroid carcinoma (FMTC), MEN-2A, and MEN-2B.
- Evidence suggests RET signal transduction involves coupling to the Shc-Ras-MAPK pathway.
Conclusions:
- The RET gene is a critical oncogene with diverse mutation-driven cancer implications.
- Understanding RET signaling is crucial for targeted cancer therapies.
- The Shc-Ras-MAPK pathway is a key mediator of RET's transforming and mitogenic signals.
Related Concept Videos
Master Transcription Regulators
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
The Y Chromosome Determines Maleness
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size. Today,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

